WebAFINITOR® (everolimus) Tablets is the only FDA-approved mTOR inhibitor that is proven to reduce tumor volume in patients who have SEGA with TSC. FDA, US Food and Drug … WebEverolimus is used to treat various types of cancer (such as kidney, breast, pancreas, lung, stomach /intestinal cancers). Everolimus is also used in people with a certain genetic …
Glioblastoma Multiforme (GBM): Advancing Treatment …
WebNov 8, 2013 · Afinitor is a prescription medicine used to treat: postmenopausal women with a type of breast cancer known as advanced hormone receptor-positive, HER2-negative breast cancer, along with Aromasin after treatment with other medication has not worked.; adults with a type of pancreatic cancer known as pancreatic neuroendocrine tumor … WebAFINITOR® (everolimus) is indicated for the treatment of renal cell carcinoma and progressive neuroendocrine tumors of pancreatic origin (PNET) in patients with … targ company
Gliomas Johns Hopkins Medicine
WebMay 26, 2024 · Afinitor is a cancer medicine that interferes with the growth of cancer cells and slows their spread in the body. Afinitor is used to treat certain types of kidney cancer, breast cancer, or brain tumor. It is also used to treat certain types of advanced or progressive tumors of the stomach, intestines, or pancreas. The more common side effects of Afinitor can include: 1. stomatitis(sores or swelling in your mouth) 2. increased risk of infections 3. rash 4. diarrhea 5. swelling of your hands, arms, feet, ankles, or legs 6. pain in your abdomen (belly) 7. nausea 8. vomiting 9. fever 10. weakness or lack of … See more Serious side effects from Afinitor can occur. Call your doctor right away if you have serious side effects. Call 911 if your symptoms feel life threatening or if you think you’re having a medical emergency. Serious side effects … See more You may wonder how often certain side effects occur with this drug. Here’s some detail on certain side effects this drug may cause. See more Infections, including serious infections, may be more common in people of all ages during Afinitor treatment. Two clinical studieslooked at children who took Afinitor. Children younger than age 6 years had higher rates of … See more WebMar 1, 2009 · Afinitor (everolimus), an inhibitor of mTOR (mammalian target of rapamycin), is an antineoplastic agent. Afinitor is specifically indicated for the following conditions: Adults with advanced renal cell carcinoma (RCC) … 顔 オイリー 化粧水